Evidence map›Paper›PMID 32713504›Full record

ArticleAnnals of epidemiology2020

Partitioning of time trends in prevalence and mortality of bladder cancer in the United States.

Igor Akushevich, Arseniy P Yashkin, Brant A Inman, Frank Sloan

Abstract read
In one paragraph

Article in Annals of epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Igor AkushevichBiodemography of Aging Research Unit, Center for Population Health and Aging, Duke University, Durham, NC.
Arseniy P YashkinBiodemography of Aging Research Unit, Center for Population Health and Aging, Duke University, Durham, NC. Electronic address: apy4@duke.edu.
Brant A InmanDepartment of Surgery, Division of Urology and Duke Cancer Institute, Duke University School of Medicine, Durham, NC.
Frank SloanDepartment of Economics, Duke University, Durham, NC.

Funding

Racial and Geographic Disparities in Risk and Survival of Alzheimer's Disease and Related DementiasR01AG066133 · NIA · DUKE UNIVERSITY · PI AKUSHEVICH, IGOR · 2019 to 2023
$3.7M
Determinants of geographic disparities in mortality and multimorbidity in the U.S.R01AG057801 · NIA · DUKE UNIVERSITY · PI AKUSHEVICH, IGOR, KRAUCHANKA, YULIYA · 2019 to 2023
$2.1M
NIA NIH HHS R01 AG057801NIA NIH HHS R01 AG066133
6 · The paper itself

Abstract

purposeThe aim of the study was to evaluate the relative contributions of incidence, stage-specific relative survival, and stage ascertainment to changes in bladder cancer (BC) prevalence and incidence-based mortality.

methodsPartitioning of prevalence and incidence-based mortality trends into their epidemiologic components.

resultsBC prevalence estimated from our model increased but at monotonically decreasing rates until 2007, after which it decreased again. The main forces underlying observed trends in BC prevalence were relative BC survival, which improved throughout the period, and BC incidence, which increased at a decreasing rate until 2005 and declined thereafter. Mortality of persons ever diagnosed with BC increased at an increasing rate until 1997, increased at a decreasing rate from 1997 to 2005, and decreased thereafter. The primary forces accounting for mortality trends were changes in mortality in the general population, which improved at an increasing rate during most of 1992-2010, the most important factor, and changes in incidence. Stage ascertainment did not improve during 1992-2010.

conclusionsAlthough mortality rates improved, these gains largely reflected improvements in U.S. population survival rather than from improvements in BC-specific outcomes.

Indexed as

AdolescentAdultAgedAged, 80 and overAge DistributionFemaleHumansIncidenceMaleMiddle AgedPrevalenceSurvival RateUnited StatesUrinary Bladder NeoplasmsBladder cancerMortalityPartitioningPrevalence

Identifiers

PMID32713504
PMCPMC7385284

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.